Egetis Therapeutics AB (EGTX.ST) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.24
-0.22
-0.19
-0.16

Details

Expected EPS
-0.24479709
Actual EPS
N/A
Surprise EPS
0.24
Surprise Percent
+100%

Description

Egetis Therapeutics AB (EGTX.ST) will report earnings of for Q1 2026 on February 26, 2026.

0 Comments

Share your thoughts